Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

Obu Health vs TRT Kingdom

Obu Health
Graded #336

Higher grade

vs+2.200000000000003
TRT Kingdom
Graded #398

Lower grade

The verdict

Obu Health takes it — 59.7/100 to 57.5/100.

Obu Health grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Obu Health is a Las Vegas-based multi-product telehealth platform offering compounded semaglutide from $190/month and compounded tirzepatide from $239/month, plus NAD+ and sermorelin add-ons.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTRT Kingdom +2
43
45
Dose & formulationObu Health +24
64
40
Clinical oversightObu Health +2
84
82
Labs & monitoringTRT Kingdom +23
53
76
FulfillmentObu Health +14
74
60
Contract termsTRT Kingdom +10
31
41
Obu Health · left barTRT Kingdom · right bar

The numbers

MetricObu HealthTRT Kingdom
WeighScore59.7/10057.5/100
GradeCC
Scorecard rank#336#398
Semaglutide$190/mo (starting dose, plus a separate fee, compounded)Not disclosed
Tirzepatide$239/mo (starting dose, plus a separate fee, compounded)Not disclosed
CoverageCoverage not publishedCoverage not published
Brand-name accessCompounded onlyCompounded only
Oral / sublingualInjection onlyInjection only
Obu Health

Graded #336 · C

Strengths

  • LegitScript-certified with publicly displayed ID (44206977)
  • Two named 503A compounding-pharmacy partners (Manifest Pharmacy SC + RX Compounding Store FL) — transparency above category baseline
  • Lower advertised semaglutide starting price ($190) than most multi-product peer platforms
  • Multi-product offering (GLP-1s + NAD+ + sermorelin + generic ED + birth control) for single-platform users
  • 24-hour US board-certified physician response window

Where it loses points

  • Per-dose pricing tiers not transparently published on product pages — only 'starting from' prices visible
  • No explicit state-coverage list disclosed; FAQ confirms restrictions exist 'based on state' without enumeration
  • Medical director not named publicly
  • No published consultation fee disclosure — unclear whether physician visit is included in medication price
  • All sales final per FAQ ('Federal and State law do not allow medication returns')
TRT Kingdom

Graded #398 · C

Strengths

  • Compounded GLP-1 and dual GLP-1/GIP options offered
  • Microdosing protocols available for men and women
  • Prescribed by licensed physician, dispensed from US pharmacy
  • CMO (Daniel Olivero) plus nurse practitioners on staff
  • Clear disclosure that compounded meds are not FDA-approved

Where it loses points

  • Weight loss is secondary to core TRT/hormone focus
  • No pricing published online
  • Specific compounding pharmacy not named
  • State licensing list not published

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard